Patents by Inventor Peter Hersey

Peter Hersey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating Stage IV melanoma
    Patent number: 10111941
    Abstract: The present invention relates to a method of treating Stage IV melanoma in a subject. The method includes the step of administering to the subject a therapeutically effective amount of a melanoma cell lysate and/or an immunotherapeutic extract, component or antigen thereof.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: October 30, 2018
    Inventors: Peter Hersey, Brendon John Coventry
  • Pharmaceutical combination comprising a B-Raf inhibitor and a histone deacetylase inhibitor and their use in the treatment of proliferative diseases
    Patent number: 9717728
    Abstract: A pharmaceutical combination comprising (a) a B-Raf inhibitor and (b) a histone deacetylase inhibitor; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: August 1, 2017
    Assignee: Novartis AG
    Inventors: Stuart John Gallagher, Peter Hersey
  • METHOD FOR TREATING STAGE IV MELANOMA
    Publication number: 20160375116
    Abstract: The present invention relates to a method of treating Stage IV melanoma in a subject. The method includes the step of administering to the subject a therapeutically effective amount of a melanoma cell lysate and/or an immunotherapeutic extract, component or antigen thereof.
    Type: Application
    Filed: September 12, 2016
    Publication date: December 29, 2016
    Inventors: Peter Hersey, Brendon John Coventry
  • Method for treating stage IV melanoma
    Patent number: 9463226
    Abstract: The present invention relates to a method of treating Stage IV melanoma in a subject. The method includes the step of administering to the subject a therapeutically effective amount of a melanoma cell lysate and/or an immunotherapeutic extract, component or antigen thereof.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: October 11, 2016
    Inventors: Peter Hersey, Brendon John Coventry
  • PHARMACEUTICAL COMBINATION COMPRISING A B-RAF INHIBITOR AND A HISTONE DEACETYLASE INHIBITOR AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
    Publication number: 20150283136
    Abstract: A pharmaceutical combination comprising (a) a B-Raf inhibitor and (b) a histone deacetylase inhibitor; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
    Type: Application
    Filed: November 8, 2013
    Publication date: October 8, 2015
    Inventors: Stuart John Gallagher, Peter Hersey
  • METHOD FOR TREATING STAGE IV MELANOMA
    Publication number: 20100221289
    Abstract: The present invention relates to a method of treating Stage IV melanoma in a subject. The method includes the step of administering to the subject a therapeutically effective amount of a melanoma cell lysate and/or an immunotherapeutic extract, component or antigen thereof.
    Type: Application
    Filed: March 28, 2006
    Publication date: September 2, 2010
    Inventors: Peter Hersey, Brendon John Coventry